Belfort et al. randomly assigned 55 patients with biopsy-confirmed NASH and either impaired glucose tolerance or type 2 diabetes to receive a hypocaloric diet plus either pioglitazone (30 mg daily ...
As 2025 arrives, experts break down the trending diets, highlighting the science-backed winners, the cautious choices to consider and the fads that might not live up to the hype.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback